Skip to main content

Table 2 Contrast of patient demographics and tumor characteristics of ILC against IDC, as stratified by geographical location

From: Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy

Characteristics

All ILC

All IDC

Sp. Cor.

p

AUS-ILC

AUS-IDC

Sp. Cor.

p

HK-ILC

HK-IDC

Sp. Cor.

p

Menopausal status (pre-, post-menopausal, MP)

  

−0.155

<0.0005

  

−0.160

0.003

  

−0.135

<0.0005

 

No. (%) Post-MP

89 (69.5%)

601 (41.3%)

  

36 (81.8%)

174 (58.6%)

  

53 (63.1%)

427 (36.8%)

  

Tumor size (≤2, >2-5, >5 cm)

  

−0.148

<0.0005

  

−0.145

<0.0005

  

−0.150

<0.0005

 

Median (cm)

2.4

1.8

  

2.4

1.8

  

2.5

1.8

  

Tumor grade (1,2,3)

  

0.205

<0.0005

  

0.138

<0.0005

  

0.239

<0.0005

 

No. (%) Grade 3

14 (6.5%)

873 (49.5%)

  

8 (8.5%)

275 (44.3%)

  

6 (4.9%)

598 (52.3%)

  

LN involvement (no, yes)

  

−0.007

0.761

  

0.007

0.852

  

−0.011

0.706

 

No. (%) Positive

96 (42.7%)

711 (41.6%)

  

40 (47.1%)

273 (48.1%)

  

56 (40.0%)

438 (38.4%)

  

ER (negative, positive)

  

−0.121

<0.0005

  

−0.131

0.001

  

−0.114

<0.0005

 

No. (%) Positive

220 (94.8%)

1416 (80.3%)

  

91 (97.8%)

512 (84.6%)

  

129 (92.8%)

904 (78.0%)

  

PR (negative, positive)

  

−0.037

0.096

  

−0.067

0.079

  

−0.018

0.511

 

No. (%) Positive

182 (79.1%)

1301 (74.0%)

  

78 (84.8%)

458 (76.6%)

  

104 (75.4%)

843 (72.7%)

  

HER2 (negative, positive)

  

0.095

<0.0005

  

0.091

0.018

  

0.093

0.001

 

No. (%) Negative

210 (91.7%)

1383 (80.3%)

  

85 (93.4%)

482 (84.0%)

  

125 (90.6%)

901 (78.5%)

  

Ki67 (≤5, 6–9, ≥10)

  

0.269

<0.0005

  

0.191

0.002

  

0.252

<0.0005

 

Median

5

15

  

5

15

  

6

15

  
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us